Immune restoration inflammatory syndromes: Apparently paradoxical clinical events after the initiation of HAART
- 65 Downloads
Immune reconstitution occurs after initiation of highly active antiretroviral therapy in immunodeficient HIV-positive individuals. Unexpected deterioration of inflammatory disease and atypical clinical features resembling symptoms of autoimmune disease may arise. These atypical inflammatory disorders, synonymously summarized as immune reconstitution syndrome, immune restoration disease, and immune restoration inflammatory syndrome (IRIS), are caused by augmentation of inflammation during immune reconstitution in an immunocompromised host. These disorders have to be distinguished from intercurrent infection and rheumatic disease, respectively. Treatment of IRIS consists of elements for both potential differential diagnoses (ie, anti-inflammatory and immunosuppressive drugs, such as in autoimmune disorders and antimicrobial chemotherapy, to decrease the burden of pathogen, such as in infectious disease). Therefore, awareness for IRIS is of increasing importance from a clinical point of view. However, diagnostic criteria and standards of treatment are still preliminary.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 10.French MA, Lenzo N, John M, et al.: Immune restoration disease after the treatment of immunodeficient HIVinfected patients with highly active antiretroviral therapy. HIV Med 2000, 1:107–115. An excellent overview of approximately 33 cases of immune restoration disease. The study was performed monocentric in Perth, Australia, involving 179 patients who started HAART during a consecutive 10-month period. The reported cases with IRIS reflect 25% of 132 patients successfully treated with HAART. Therefore, this study characterizes a realistic spectrum of disease. Pathophysiologic aspects of these cases have been investigated and discussed by a group of immunologists and clinicians.PubMedCrossRefGoogle Scholar
- 11.Cheng VC, Yuen KY, Chan WM, et al.: Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis 2000, 30:882–892. The outstanding merit of this review of more than 100 cases is the broad definition of immune restoration inflammatory diseases, which is not exclusively related to HIV infection or T-cell immunodeficiencies.PubMedCrossRefGoogle Scholar
- 13.Stone SF, Price P, Tay K, French MA: Cytomegalovirus (CMV) retinitis immune restoration disease occurs during highly active antiretroviral therapy-induced restoration of CMV specific immune responses within a predominant Th2 cytokine environment. J Infect Dis 2002, 185:1813–1817.PubMedCrossRefGoogle Scholar
- 27.Stone SF, Lee S, Keane NM, et al.: Association of increased hepatitis C virus (HCV)-specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patients. J Infect Dis 2002, 186:1498–1502.PubMedCrossRefGoogle Scholar
- 50.Price P, Morahan G, Huang D, et al.: Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases. AIDS 2002, 16:2043–2047. In addition to previously described associations of IRIS to certain histocompatibility antigens and distinct patterns of immunoreconstitution, this study demonstrates that polymorphisms of genetic factors have an impact on the manifestation of IRIS.PubMedCrossRefGoogle Scholar